Following a report in the Mirror yesterday of a massive rise in diagnosis of advanced prostate cancer in the United States and a call for more PSA screening there, our resident expert Dr Sophie Lutter cautions against such an approach here.
Thanks to the tenacity of our volunteers, giving talks and manning stands across Britain, our three-year awareness programme has hit its target of reaching 350,000 people with four months still to go.
The Labour MP for Streatham pledges his support to Prostate Cancer UK to help raise awareness among black men, who have double the risk of white men of developing the disease, as we continue to fund research into why this ethnic discrepancy exists.
When Ian Adamson tells us why he filled in the Life After Prostate Cancer survey, and how his experience of being diagnosed and treated for prostate cancer left him feeling it can all be a bit of a lottery how well you fare.
The array of treatment options often felt bewildering to Courtenay King after he was first diagnosed with prostate cancer. Now he hopes that by participating in the 'Life after prostate cancer diagnosis' study, he can help improve others' experience of dealing with the disease.
The first of our 'Life after prostate cancer diagnosis' surveys will drop on the doormats of men with prostate cancer in Northern Ireland today, as the groundbreaking study extends beyond England, with Wales and Scotland due in the next few months.
As new research emerges to confirm that over 11% of men with advanced prostate cancer have inherited mutations in genes that repair breaks in our DNA, we speak to Sarah Rose, a genetic counsellor at Guys and St Thomas’ NHS Trust, about the current availability of genetic testing for men with prostate cancer on the NHS and the difficult questions it raises.
Research published today has discovered a far higher proportion of inherited DNA mutations in men with advanced prostate cancer than previously suspected, opening up new possibilities for targeted treatments.
BLOG: At this year's annual meeting of the British Association of Urological Surgeons, it was the exciting potential of mpMRI scans before a biopsy that had attendees buzzing. We were there to help make the case for the new diagnostic tool and our Change Delivery Officer, Jade Fairfax, reports on how it led to a commitment from urologists and BAUS to roll out mpMRI across the UK.
We call for change after the results of NHS England's National Cancer Patient Experience Survey, released today, show unacceptable regional variations in support and access to specialist nurses for men with prostate cancer.